Key Highlights

  • FormFactor closed at $113.34 on October 15, down 5.32%.
  • FormFactor is a semiconductor test and probe supplier.
  • Semiconductor and AI-linked shares sold off across the market.
  • The Nasdaq Composite fell about 2% and the S&P 500 about 1.15% on the session.

FormFactor (NASDAQ:FORM) closed at $113.34 on Thursday, October 15, 2026, down 5.32% in a session that weighed heavily on semiconductor shares and the companies that supply the industry. FormFactor fell because it sits firmly within the chip complex, the part of the market investors were abandoning that day amid fears about interest rates and the durability of spending on artificial intelligence.

FormFactor and the Chip Sell-Off

FormFactor makes probe cards and related test and measurement products used to verify semiconductors during manufacturing. A probe card is the precision interface that connects automated test equipment to the tiny contact points on a wafer, allowing chipmakers to check that devices function correctly before they are cut from the wafer and packaged. The company also supplies systems and components for engineering and failure analysis. Because its products are consumed across a wide range of chip types, including the advanced logic and memory devices central to AI and high-performance computing, FormFactor’s fortunes track the health and capital-spending appetite of the broader semiconductor industry. That makes it a classic “picks and shovels” name, and one that moves closely with sentiment toward chips.

Thursday was a difficult day for that sentiment. The Philadelphia Semiconductor Index fell roughly 2.4%, its seventh straight decline, bringing its loss over seven sessions to more than 14%. The selling was broad and deep: Nvidia (NASDAQ:NVDA) dropped about 3.3%, AMD (NASDAQ:AMD) around 6.4% and Micron (NASDAQ:MU) close to 5%, while information technology was the heaviest drag on the S&P 500, which lost roughly 1.15%. The Nasdaq Composite fell about 2% to a one-month low. In that environment, an equipment and test supplier like FormFactor was always likely to be sold alongside the chipmakers it serves, and a 5.32% decline reflects the leverage such names carry to the industry’s capital-spending cycle.

The drivers were macro and thematic rather than company-specific. A hotter-than-expected September inflation report and the sharpest jump in producer prices in roughly four and a half years led markets to raise the odds of further Federal Reserve rate increases. Investors worried that higher borrowing costs could crimp the vast capital spending behind the AI build-out and questioned whether the cash flows underpinning that spending would hold up as rates rose. A cautious 2027 outlook from a leading foundry, citing macro uncertainty, added to the unease about future chip demand. For a supplier whose revenue depends on manufacturers continuing to invest, any wobble in the industry’s spending outlook tends to be felt immediately in the shares.

FormFactor in the AI Sell-Off

The most accurate description is that the stock was carried lower by a sector-wide sell-off rooted in rate and AI-funding fears, not by anything unique to the business. For equipment and test names tightly linked to chip-industry capital expenditure, repricing of this kind can occur purely on shifting expectations, with no new information about the company itself.

The FormFactor Takeaway

The day was not uniformly negative across the market. Defensive sectors such as healthcare and consumer staples rallied as investors rotated toward safety, and the 10-year Treasury yield slipped to a roughly three-week low as money moved into government bonds. But that rotation into defensives was exactly the headwind facing chip and chip-equipment stocks; capital was leaving the semiconductor and AI-exposed part of the market where FormFactor resides.

A single session reveals little about the company’s longer-term prospects, and higher-beta equipment names can swing meaningfully in both directions. Thursday’s move is best understood as FormFactor participating in a broad repricing of semiconductor equities rather than responding to anything specific to the firm.